Although we may think of migraine as a disease of adults, it can also affect children of all ages. Some studies show migraine affects 6% of children and up to 28% of adolescents ages 15-17. To assist ...

April 22, 2008 (Chicago, Illinois) — In children and teenagers with both headaches and sleep complaints, a new study using polysomnography showed an association between migraine and sleep-disordered ...

Fremanezumab yields a greater reduction in the number of migraine days and headache days than placebo among children and adolescents with episodic migraine, according to a study published in the Jan.

(NAPSI)—Migraine is a debilitating neurological disease that affects one billion people worldwide, but it is not just an adult disease. For the 1 in 10 children diagnosed with this complex and ...

Migraines are frequently underdiagnosed and undertreated, Seacoast doctor writes. NH joins national advocacy effort on ...

For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study. Researchers found the drug zonisamide, which has been used to treat seizures, ...

CINCINNATI (WKRC) - A medication previously available only for adults is now on the market for children to help reduce migraines. Recent research focused on children aged six to 17 and examined a ...

SAN DIEGO -- Fremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE trial. The phase III study showed a reduction in monthly migraine ...

September 7, 2006 -- Oral rizatriptan ( Maxalt, Merck) is a highly effective and well-tolerated treatment for migraine attacks in children and adolescents, a new study suggests. In a double-blind, ...

A lesser-known type of migraine is showing up in children, and unlike typical migraines, it doesn’t involve head pain. Abdominal migraines are characterized by episodes of abdominal pain, nausea, and ...

The number of migraine days per month was 2.5 with fremanezumab vs 1.4 with placebo. HealthDay News — Fremanezumab yields a greater reduction in the number of migraine days and headache days than ...